These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15555141)

  • 41. [Obsessive-compulsive disorders: how to recognize and treat them].
    Walh K; Kordon A; Hohagen F
    MMW Fortschr Med; 2005 Sep; 147(35-36):42-5. PubMed ID: 16180571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological treatments for obsessive-compulsive disorder in children and adolescents: a qualitative review.
    Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
    Actas Esp Psiquiatr; 2013; 41(3):196-203. PubMed ID: 23803803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions.
    Polman A; Bouman TK; van Hout WJ; de Jong PJ; den Boer JA
    Clin Psychol Psychother; 2010; 17(1):1-12. PubMed ID: 19658125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive treatment of three patients with comorbid OCPD and ADHD.
    Josephson SC; Hollander E; Sumner J
    CNS Spectr; 2007 May; 12(5):338-42. PubMed ID: 17514078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis.
    Sánchez-Meca J; Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
    J Anxiety Disord; 2014 Jan; 28(1):31-44. PubMed ID: 24334214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnosis and therapy of obsessive-compulsive disorders].
    Hand I
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():1-2. PubMed ID: 7635388
    [No Abstract]   [Full Text] [Related]  

  • 49. [Combination treatment in children and adolescent with obsessive compulsive disorders].
    Wewetzer C; Walitza S
    MMW Fortschr Med; 2005 Dec; 147(48):36, 38-40. PubMed ID: 16389860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.
    Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB
    Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [To identify and treat obsessive-compulsive disorders: an overview].
    Voderholzer U; Hauer M; Stattrop U
    MMW Fortschr Med; 2013 Sep; 155(15):37-9. PubMed ID: 24224373
    [No Abstract]   [Full Text] [Related]  

  • 52. Obsessive-compulsive disorder: Under-recognized and responsive to treatment.
    Craner JR; Skillings JL; Barnes CR
    J Fam Pract; 2017 Aug; 66(8):503-506. PubMed ID: 28783772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
    Cottraux J; Bouvard MA; Milliery M
    Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
    Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
    Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of antipsychotics in the treatment of obsessive compulsive disorder.
    Fineberg NA; Gale TM; Sivakumaran T
    J Psychopharmacol; 2006 Jan; 20(1):97-103. PubMed ID: 16204331
    [No Abstract]   [Full Text] [Related]  

  • 56. Behavior therapy and serotonin dysregulation.
    Taylor S
    J Clin Psychiatry; 1997 Jul; 58(7):323-4. PubMed ID: 9269255
    [No Abstract]   [Full Text] [Related]  

  • 57. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
    Vloet TD; Simons M; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CBT-pharmacotherapy combo lessens pediatric OCD symptoms.
    J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):7, 47. PubMed ID: 22066658
    [No Abstract]   [Full Text] [Related]  

  • 59. Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent.
    Ramasubbu R
    Arch Gen Psychiatry; 2002 May; 59(5):472; author reply 472-3. PubMed ID: 11982460
    [No Abstract]   [Full Text] [Related]  

  • 60. Comorbid tics have no effect on response to cognitive-behavioral therapy in youth with obsessive-compulsive disorder.
    Hanna GL
    Evid Based Ment Health; 2015 Aug; 18(3):85. PubMed ID: 26126872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.